Verona Pharma plc Operational Update and Financial Results for the Three Months Ended March 31, 2019

NEXT STORY
Glycol Ether Market to exceed $8.5bn by 2025: Global Market Insights, Inc.
PREV STORY
Novartis presents first-of-its-kind algorithm-based tool to help MS patients and physicians evaluate and discuss early signs of progression to secondary progressive MS
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

World Experts in Infectious Diseases & Critical Care Form Pluristem’s COVID-19 Steering Committee

author_avatar
NASDAQ Market News

Everest Medicines Announces The China Center for Drug Evaluation, National Medical Products Administration Recommends Breakthrough Therapy Designation for Nefecon for the Treatment of IgA Nephropathy

author_avatar
NASDAQ Market News

Santhera Enters into Exclusive License Agreement with Sperogenix for Vamorolone in Rare Diseases in the Greater China Region

author_avatar
NASDAQ Market News